Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting.
Barnebey, H
Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting. [electronic resource] - Clinical therapeutics Oct 2000 - 1204-12 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0149-2918
10.1016/s0149-2918(00)83063-5 doi
Carbonic Anhydrase Inhibitors--adverse effects
Glaucoma--drug therapy
Humans
Intraocular Pressure--drug effects
Patient Satisfaction
Prospective Studies
Sulfonamides--adverse effects
Thiazines--adverse effects
Thiophenes--adverse effects
Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting. [electronic resource] - Clinical therapeutics Oct 2000 - 1204-12 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0149-2918
10.1016/s0149-2918(00)83063-5 doi
Carbonic Anhydrase Inhibitors--adverse effects
Glaucoma--drug therapy
Humans
Intraocular Pressure--drug effects
Patient Satisfaction
Prospective Studies
Sulfonamides--adverse effects
Thiazines--adverse effects
Thiophenes--adverse effects